Showing results (221-230 of 543) with videos related to
Sort By:
Pageof 55
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.Human Mutation|August 10, 2005
Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus)Xiao-Tao Wang, Veronica M S Lam, Paul C EngelJournal of Biotechnology|September 26, 2006
Phenylalanine dehydrogenase mutants: efficient biocatalysts for synthesis of non-natural phenylalanine derivativesFrancesca Paradisi, Stuart Collins, Anita R Maguire, et al.Klinische Padiatrie|September 1, 1984
[Seizures in premature and newborn infants under 2,500 grams birth weight]F Staudt, G J Benda, J Howieson, et al.FEBS Letters|May 10, 2005
Identification of the residue responsible for catalysing regeneration of activity in the inactive glutamate dehydrogenase mutant D165NFrancesca Paradisi, Ruth Woolfson, Kieran F Geoghegan, et al.British Medical Journal (Clinical Research Ed.)|January 2, 1988
Acylcoenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in the liverF Allison, M J Bennett, S Variend, et al.Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 1, 1985
[Results of percutaneous transhepatic bile duct drainage]K Lackner, A Steudel, R Bäuerle, et al.Traffic (Copenhagen, Denmark)|March 22, 2001
Secretory and endocytic pathways converge in a dynamic endosomal system in a primitive protozoanE Ghedin, A Debrabant, J C Engel, et al.Biochimica Et Biophysica Acta|August 29, 2006
Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleXiao-Tao Wang, Veronica M S Lam, Paul C EngelAnnals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG)C Engel, M Loeffler, S Schmitz, et al.Pageof 55